Landmark victory for individuals living with DEB and their families, the FDA announced their approval of Krystal Biotech’s VYJUVEK™ for the treatment of Dystrophic Epidermolysis Bullosa (DEB).

Investors look past US tech sector as uncertain environment clouds outlook

Prominent NYC-based pastor and best-selling author Timothy Keller dies at 72

Mexican peso to stay strong despite end of cenbank tightening cycle - analysts

Eternal space division wins NASA competition

Ukraine war: US to support providing F-16 fighter jets to Ukraine

Alberta, Canada, wildfires show no sign of slowing, experts say

Montana could sign law defining sex, raising transgender rights concerns

Premier League predictions: Gameweek 37

8 Things You Might Not Know About 'The Joy Luck Club'

MLS News: San Diego announced as 30th MLS Team

DeSantis meets New Hampshire lawmakers, greets voters ahead of expected 2024 announcement